- Home
- AU vs GEHC Comparison
AU vs GEHC Comparison
Compare AU & GEHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AU
- GEHC
- Stock Information
- Founded
- AU 1944
- GEHC 1892
- Country
- AU United States
- GEHC United States
- Employees
- AU N/A
- GEHC N/A
- Industry
- AU Precious Metals
- GEHC Computer Software: Prepackaged Software
- Sector
- AU Basic Materials
- GEHC Technology
- Exchange
- AU Nasdaq
- GEHC Nasdaq
- Market Cap
- AU 34.6B
- GEHC 33.1B
- IPO Year
- AU 1972
- GEHC N/A
- Fundamental
- Price
- AU $78.88
- GEHC $73.28
- Analyst Decision
- AU Buy
- GEHC Buy
- Analyst Count
- AU 6
- GEHC 9
- Target Price
- AU $63.33
- GEHC $86.11
- AVG Volume (30 Days)
- AU 3.4M
- GEHC 3.5M
- Earning Date
- AU 11-11-2025
- GEHC 10-29-2025
- Dividend Yield
- AU 1.17%
- GEHC 0.19%
- EPS Growth
- AU 1303.37
- GEHC 32.35
- EPS
- AU 3.81
- GEHC 4.83
- Revenue
- AU $7,649,000,000.00
- GEHC $20,246,000,000.00
- Revenue This Year
- AU $70.41
- GEHC $6.41
- Revenue Next Year
- AU $11.47
- GEHC $4.44
- P/E Ratio
- AU $19.46
- GEHC $15.20
- Revenue Growth
- AU 54.59
- GEHC 3.51
- 52 Week Low
- AU $22.45
- GEHC $57.65
- 52 Week High
- AU $79.94
- GEHC $94.80
- Technical
- Relative Strength Index (RSI)
- AU 65.67
- GEHC 43.73
- Support Level
- AU $63.29
- GEHC $72.21
- Resistance Level
- AU $69.64
- GEHC $76.81
- Average True Range (ATR)
- AU 2.34
- GEHC 2.13
- MACD
- AU 0.73
- GEHC -0.39
- Stochastic Oscillator
- AU 99.57
- GEHC 16.45
About AU AngloGold Ashanti PLC
Anglogold Ashanti PLC is one of the gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from the Africa region which includes its operations of the Kibali, Iduapriem, Obuasi, Siguiri, and Geita mines.
About GEHC GE HealthCare Technologies Inc.
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).